Virtual Medicinal Product (VMP) - Abacavir 300mg / Lamivudine 150mg / Zidovudine 300mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Abacavir 300mg / Lamivudine 150mg / Zidovudine 300mg tablets Start Date 02-04-2025 End Date
Previous Name Previous Name Generic Trizivir tablets Start Date 21-05-2003 End Date 01-04-2025

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
J05AR04
BNF Start Date End Date
Current BNF 05030100 Start Date 04-04-2022 End Date
Previous BNF 05030100 Start Date 23-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
4435711000001101 21-05-2003

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Abacavir sulfate Based on Base Substance Abacavir 300 mg
Lamivudine Based on Ingredient Substance 150 mg
Zidovudine Based on Ingredient Substance 300 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
60 tablet